NCT02449902View on ClinicalTrials.gov

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
MenopauseVulvovaginal AtrophyPainful IntercourseDyspareunia
Interventions
DRUG

Estradiol

1 10 µg capsule inserted vaginally for 14 days.

DRUG

placebo

1 placebo capsule inserted vaginally for 14 days.

Trial Locations (1)

32720

Avail Clinical Research, DeLand

Sponsors

Lead Sponsor

TherapeuticsMD
All Listed Sponsors
lead

TherapeuticsMD

INDUSTRY

NCT02449902 - TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy | Biotech Hunter | Biotech Hunter